Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1960 Feb;39(2):262–265. doi: 10.1172/JCI104036

THE ROLE OF HUMAN COAGULATION FACTORS IN SERUM-INDUCED THROMBOSIS *

Stanford Wessler 1,2, Stanley M Reimer 1,2, Mary-Lou Bloede 1,2, Marjorie Nickles 1,2, Bela J Szalai 1,2
PMCID: PMC441803  PMID: 13844119

Full text

PDF
263

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER B. Clotting factor VII (proconvertin): synonymy, properties, clinical and clinicolaboratory aspects. N Engl J Med. 1959 Jun 11;260(24):1218–1222. doi: 10.1056/NEJM195906112602405. [DOI] [PubMed] [Google Scholar]
  2. BIGGS R., DOUGLAS A. S. The thromboplastin generation test. J Clin Pathol. 1953 Feb;6(1):23–29. doi: 10.1136/jcp.6.1.23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DE NICOLA P. Factor VII (SPCA): its physiopathologic significance. Blood. 1953 Oct;8(10):947–954. [PubMed] [Google Scholar]
  4. KOLLER F., LOELIGER A., DUCKERT F. Experiments on a new clotting factor (factor VII). Acta Haematol. 1951;6(1):1–18. doi: 10.1159/000203899. [DOI] [PubMed] [Google Scholar]
  5. LOELIGER A., KOLLER F. Behaviour of factor VII and prothrombin in late pregnancy and in the newborn. Acta Haematol. 1952 Mar;7(3):157–161. doi: 10.1159/000204048. [DOI] [PubMed] [Google Scholar]
  6. OWREN P. A., AAS K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest. 1951;3(3):201–208. doi: 10.3109/00365515109060600. [DOI] [PubMed] [Google Scholar]
  7. RAPAPORT S. I., AAS K., OWREN P. A. The effect of glass upon the activity of the various plasma clotting factors. J Clin Invest. 1955 Jan;34(1):9–19. doi: 10.1172/JCI103067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. RATNOFF O. D., ROSENBLUM J. M. Role of Hageman factor in the initiation of clotting by glass; evidence that glass frees Hageman factor from inhibition. Am J Med. 1958 Aug;25(2):160–168. doi: 10.1016/0002-9343(58)90023-8. [DOI] [PubMed] [Google Scholar]
  9. SISE H. S., LAVELLE S. M., ADAMIS D., BECKER R. Relation of hemorrhage and thrombosis to prothrombin during treatment with coumarin-type anticoagulants. N Engl J Med. 1958 Aug 7;259(6):266–271. doi: 10.1056/NEJM195808072590603. [DOI] [PubMed] [Google Scholar]
  10. SPAET T. H., KROPATKIN M. Effect of intravenous blood thromboplastin intermediates on clotting in rats. Am J Physiol. 1958 Oct;195(1):77–80. doi: 10.1152/ajplegacy.1958.195.1.77. [DOI] [PubMed] [Google Scholar]
  11. WESSLER S., BALLON J. D., KATZ J. H. Studies in intravascular coagulation. V. A distinction between the anticoagulant and antithrombotic effects of dicumarol. N Engl J Med. 1957 Jun 27;256(26):1223–1225. doi: 10.1056/NEJM195706272562604. [DOI] [PubMed] [Google Scholar]
  12. WESSLER S., REIMER S. M., SHEPS M. C. Biologic assay of a thrombosis-inducing activity in human serum. J Appl Physiol. 1959 Nov;14:943–946. doi: 10.1152/jappl.1959.14.6.943. [DOI] [PubMed] [Google Scholar]
  13. WESSLER S. Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis. J Clin Invest. 1955 Apr;34(4):647–651. doi: 10.1172/JCI103114. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES